Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor PK/PD in Chinese Patients with Stable CHD
NCT02064985Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary heart disease (CHD), sponsored by AstraZeneca. Started Feb 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT02064985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02064985.